NCT07409961

Brief Summary

Fetal anemia one of serious fetal problems that may lead in sever cases to fetal demise early detection and precise intervention safe fetal life , traditional evaluation the severity and need of blood transfusion done by middle cerebral artery peak systolic velocity in doppler wave, in this study innovative technique suggested to compared with standard technique

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
13mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Mar 2026Jun 2027

First Submitted

Initial submission to the registry

February 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 7, 2026

Last Update Submit

February 7, 2026

Conditions

Fetal Anemia

Outcome Measures

Primary Outcomes (1)

  • acceleration time in middle cerebral artery doppler

    time in millisecond in middle cerebral artery waveform from beginning of systole to reaching peak velocity

    5 minutes

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant women with fetus complaining hyperdynamic state or fetal anemia

You may qualify if:

  • fetus with fetal anemia or hyperdynamic state

You may not qualify if:

  • associated fetal congenital anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Sief Ali

CONTACT

01004971596siefali-2020@aun.edu.eg

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

February 7, 2026

First Posted

February 13, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

February 13, 2026

Record last verified: 2026-02